NASDAQ:VRTX

Vertex Pharmaceuticals Stock News

etoro logo Buy VRTX
*Your capital is at risk
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Park Avenue Securities LLC lowered its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 8.2% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 13

My Top 3 Drug Stocks for March 2026

06:30am, Friday, 20'th Mar 2026
Innovative drugmakers tend to perform well over the long run. These three drug stocks can launch new products while maintaining or improving their financial results.
Eli Lilly has strong momentum thanks to its leadership in the weight loss market. Vertex Pharmaceuticals' core franchise and newer approvals could drive top-line growth for a long time.
Danske Bank A S purchased a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $451.59, denoting a -2.36% move from the preceding trading day.
U.S. President Donald Trump pledged to make prescription drugs cheaper for Americans than anywhere in the world, but his TrumpRx.gov website is not delivering across the board lower prices than those
Bamco Inc. NY trimmed its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 42.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned
Aquatic Capital Management LLC bought a new stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) during the undefined quarter, according to the company in its most recent filing with the Securi

Is Vertex Pharmaceuticals Heading to $600?

09:15pm, Sunday, 15'th Mar 2026
The biotech company is the leader in the cystic fibrosis market and is quickly expanding into other treatment areas. Vertex forecasts its newer medicines may add $500 million to revenue this year.
Alliancebernstein L.P. lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 3.3% in the undefined quarter, according to its most recent Form 13F filing with the Securities and
Zacks.com users have recently been watching Vertex (VRTX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $492.38, representing a -1.36% change from its previous close.
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript
Vertex (VRTX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Blair William and Co. IL reduced its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 31.0% in the undefined quarter, according to the company in its most recent 13F filing
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE